AVROBIO

+$0.0178 (+2.00%) Today
$0.00 (0.00%) As of 9:16 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVROBIO and other ETFs, options, and stocks.

About AVRO

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen.

CEO
Geoff MacKay
Employees
122
Headquarters
Cambridge, Massachusetts
Founded
2015

AVRO Key Statistics

Market cap
39.66M
Price-Earnings ratio
—
Dividend yield
—
Average volume
343.84K
High today
$0.9511
Low today
$0.85
Open price
$0.8736
Volume
462.40K
52 Week high
$11.00
52 Week low
$0.74

AVRO Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure